tiprankstipranks
Heron Therapeutics Inc (HRTX)
:HRTX
US Market

Heron Therapeutics (HRTX) Income Statement

Compare
1,554 Followers

Heron Therapeutics Income Statement

Last quarter (Q3 2024), Heron Therapeutics's total revenue was $42.27M, an increase of 34.47% from the same quarter last year. In Q3, Heron Therapeutics's net income was $-4.85M. See Heron Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 127.04M$ 107.67M$ 86.35M$ 88.64M$ 145.97M
Gross Profit
$ 61.94M$ 52.80M$ 40.33M$ 52.45M$ 84.35M
Operating Expenses
$ 172.55M$ 227.46M$ 258.15M$ 280.61M$ 295.04M
Depreciation and Amortization
$ 2.90M$ 2.89M$ 3.02M$ 2.85M$ 2.04M
EBITDA
$ -103.79M$ -176.66M$ -215.25M$ -222.53M$ -201.23M
Operating Income
$ -110.61M$ -174.66M$ -217.83M$ -228.16M$ -210.69M
Other Income/Expenses
$ 56.00K$ -7.37M$ -2.85M$ 885.00K$ 5.95M
Pretax Income
$ -110.56M$ -182.02M$ -220.68M$ -227.28M$ -204.75M
Net Income
$ -110.56M$ -134.52M$ -217.66M$ -224.43M$ -204.75M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.80$ -1.24$ -2.21$ -2.47$ -2.50
Diluted EPS
$ -0.80$ -1.24$ -2.21$ -2.47$ -2.50
Weighted Average Shares Outstanding
138.13M 108.88M 98.47M 90.77M 81.78M
Weighted Average Shares Outstanding (Diluted)
138.13M 108.88M 98.47M 90.77M 81.78M
Currency in USD

Heron Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis